Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Vaccine

• Publication date

  2005-10-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.VACCINE.2005.06.011PMID 16046037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a novel inner-core oligosaccharide structure in Neisseria meningitidis lipopolysaccharide.

  2003cited by this paper
• Conjugation of meningococcal lipooligosaccharides through their lipid A terminus conserves their inner epitopes and results in conjugate vaccines having improved immunological properties.

  2003cited by this paper
• Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.

  2003cited by this paper
• Reverse vaccinology: a genome-based approach for vaccine development

  2002cited by this paper
• Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide.

  2002cited by this paper
• Gene Expression Profile in Neisseria meningitidis and Neisseria lactamica upon Host‐Cell Contact

  2002cited by this paper
• Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

  2000cited by this paper
• The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.

  1999cited by this paper
• Conservation and Accessibility of an Inner Core Lipopolysaccharide Epitope of Neisseria meningitidis

  1999cited by this paper
• Differences in Surface Expression of NspA amongNeisseria meningitidis Group B Strains

  1999cited by this paper
• Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1.

  1998cited by this paper
• Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes.

  1997cited by this paper
• Functional Relationships of the Genetic Locus Encoding the Glycosyltransferase Enzymes Involved in Expression of the Lacto-N-neotetraose Terminal Lipopolysaccharide Structure in Neisseria meningitidis*

  1996cited by this paper
• Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis.

  1993cited by this paper
• Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.

  1992cited by this paper
• The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.

  1991cited by this paper
• Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis.

  1990cited by this paper
• Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.

  1990cited by this paper
• The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis.

  1983cited by this paper
• Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

  1983cited by this paper
• TYPE-III HYPERUPOPROTEINÆMIA

  1977cited by this paper
• Quantitative Determination of Monosaccharides as Their Alditol Acetates by Gas Liquid Chromatography.

  1965cited by this paper

• Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

  2022cites this paper
• Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response

  2019cites this paper
• Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.

  2017cites this paper
• First characterization of immunogenic conjugates of Vi negative Salmonella Typhi O-specific polysaccharides with rEPA protein for vaccine development.

  2017cites this paper
• Protein recognition of clinically-relevant carbohydrates

  2015cites this paper
• Inhibition of the Alternative Pathway of Nonhuman Infant Complement by Porin B2 Contributes to Virulence of Neisseria meningitidis in the Infant Rat Model

  2014cites this paper
• Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides

  2013cites this paper
• Preclinical evaluation of MenB vaccines: prerequisites for clinical development

  2013cites this paper
• Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain.

  2012cites this paper
• Outer Membrane Vesicles of Bacteria

  2012cites this paper
• Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

  2012cites this paper
• Improvement of Immunogenicity of Meningococcal Lipooligosaccharide by Coformulation with Lipidated Transferrin-Binding Protein B in Liposomes: Implications for Vaccine Development

  2012cites this paper
• Neglected infectious diseases in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori.

  2012cites this paper
• Outer Membrane Vesicles: Physiological Medical Applications

  2012cites this paper
• Determination of in vivo toxicity and in vitro cytotoxicity of lipopolysaccharide isolated from Salmonella Enteritidis and its potential use for production of polyclonal antibody

  2011cites this paper
• Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.

  2011cites this paper
• Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera

  2011cites this paper
• Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B

  2011influential citation
• New frontiers in meningococcal vaccines

  2011cites this paper
• Investigating the candidacy of lipopolysaccharide-based glycoconjugates as vaccines to combat Mannheimia haemolytica

  2011influential citation
• Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

  2010cites this paper
• Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading

  2010cites this paper
• Isolation and purification of O and H antigens from Salmonella Enteritidis as diagnostic tool

  2010cites this paper
• Serogroup B meningococcal vaccines-an unfinished story.

  2010cites this paper
• Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading

  2010cites this paper
• Production of Monoclonal Antibodies in a Mouse Model via Lipopolysaccharide Conjugates with Synthetic Polymers Specific to Salmonella Enteritidis O Antigen

  2010cites this paper
• Review of meningococcal group B vaccines.

  2010cites this paper
• Serum antibodies to Vibrio vulnificus biotype 3 lipopolysaccharide and susceptibility to disease caused by the homologous V. vulnificus biotype

  2010cites this paper
• Application of Mass Spectrometry to Rapid Analysis of Bacterial Polysaccharides

  2010cites this paper
• Phosphoethanolamine is located at the 6-position and not at the 7-position of the distal heptose residue in the lipopolysaccharide from Neisseria meningitidis.

  2009cites this paper
• residue in the lipopolysaccharide from Neisseria meningitidis

  2009cites this paper
• Neisseria meningitidis Escape from the Bactericidal Activity of a Monoclonal Antibody Is Mediated by Phase Variation of lgtG and Enhanced by a Mutator Phenotype

  2008cites this paper
• Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.

  2008cites this paper
• Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2

  2008cites this paper
• Effect of the HP0159 ORF mutation on the lipopolysaccharide structure and colonizing ability of Helicobacter pylori.

  2008cites this paper
• E¡ect of the HP0159 ORF mutation on the lipopolysaccharide structure and colonizing ability of Helicobacterpylori

  2008cites this paper
• Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures.

  2008cites this paper
• Serological and molecular characteristics of Vibrio vulnificus biotype 3: evidence for high clonality.

  2007cites this paper
• Arraying glycomics: a novel bi-functional spacer for one-step microscale derivatization of free reducing glycans.

  2006cites this paper
• O-Acetylation of the Terminal N-Acetylglucosamine of the Lipooligosaccharide Inner Core in Neisseria meningitidis

  2006cites this paper
• Production of a D-glycero-D-manno-heptosyltransferase mutant of Mannheimia haemolytica displaying a veterinary pathogen specific conserved LPS structure; development and functionality of antibodies to this LPS structure.

  2006cites this paper
• Affinity-Purified Human Immunoglobulin G That Binds a Lacto-N-Neotetraose-Dependent Lipooligosaccharide Structure Is Bactericidal for Serogroup B Neisseria meningitidis

  2006cites this paper